Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - CytoDyn Inc. | d92787dex321.htm |
EX-31.2 - EX-31.2 - CytoDyn Inc. | d92787dex312.htm |
10-Q - FORM 10-Q - CytoDyn Inc. | d92787d10q.htm |
EX-10.1 - EX-10.1 - CytoDyn Inc. | d92787dex101.htm |
EX-31.1 - EX-31.1 - CytoDyn Inc. | d92787dex311.htm |
Exhibit 32.2
Certification of Chief Financial Officer
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
In connection with the Quarterly Report of CytoDyn Inc. (the Company) on Form 10-Q for the fiscal quarter ended August 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the Form 10-Q), I, Michael D. Mulholland, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that based on my knowledge:
(1) The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: October 9, 2015 | /s/ Michael D. Mulholland | |||
Michael D. Mulholland | ||||
Chief Financial Officer |